The Impact of Hypertension on Treatment Outcomes in Benign Prostatic Hyperplasia Patients: A Comprehensive Systematic Review
Abstract
Around 25% of men over 60 suffer from both hypertension and benign prostatic hyperplasia (BPH), two prevalent age-related illnesses that affect males. Through an analysis of the literature over the past ten years, this study attempts to thoroughly assess the effect of hypertension on the treatment outcomes of patients with BPH. Initially, 500 papers were obtained from internet databases such as Google Scholar, SpringerLink, SagePub, and PubMed. Following three screening stages, eight pertinent papers were chosen for full-text examination. The impact of hypertension on BPH treatment outcomes—including symptom severity, drug response, and surgical outcomes—was evaluated in these articles. The findings indicate that hypertension is associated with poorer treatment outcomes in BPH patients, including reduced efficacy of alpha-blockers and 5-alpha-reductase inhibitors, as well as an increased risk of surgical complications. In clinical practice, the study highlights the necessity of coordinated care approaches that manage both hypertension and BPH. In order to manage these two illnesses concurrently, healthcare providers must take a comprehensive strategy, taking into account possible drug interactions and improving treatment approaches. In order to create specialized treatment plans for this high-risk group, more study is required to examine the underlying mechanisms that connect hypertension to the development of BPH and treatment response. In the end, this would improve the…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.